低密度リポプロテイン受容体に結合するアポリポプロテインB100の構造
Mart Reimund1, Altaira D Dearborn2, Giorgio Graziano1
1Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Nature
|December 11, 2024
まとめ
アポリポプロテインB100 (apoB100) とLDL受容体 (LDLR) の相互作用に関する構造的な洞察は,突然変異が家族性高コレステロール血症を引き起こす方法を明らかにし,心血管疾患の治療のための標的を提供している.
科学分野:
- 構造生物学
- 生物化学
- 心血管研究
背景:
- アポリポプロテインB100 (apoB100) は低密度リポプロテイン (LDL) の構造とLDLR結合に不可欠です.
- apoB100またはLDLRの変異は家族性高コレステロール血症を引き起こし,心血管疾患のリスクを高めます.
- apoB100とLDLRの相互作用の構造的根拠は,ほとんど不明である.
研究 の 目的:
- LDLRに結合したapoB100の高解像度構造を解明する.
- 家族性高コレステロール血症におけるLDL-LDLR相互作用の基礎となる分子機構とその役割を理解する.
主な方法:
- 複雑な構造を決定するために,冷凍電子顕微鏡 (cryo-EM) が使用されました.
- インタラクションインターフェースの高解像度を達成するために,局所的な精錬が利用されました.
- 家族性高コレステロール血症に関連する変異部位の分析
主要な成果:
- 2つの主要な apoB100-LDLR 結合インターフェースの詳細な構造が解明されました.
- 1つのインターフェースは,LDLRリガンド結合モジュールとapoB100のβ帯を含む.
- 2つ目のインターフェースは,LDLRのベータプロペラドメインとapoB100のN端を結ぶ.
- これらのインターフェースがLDL二重体形成とLDLR構成の変化をどのように媒介するのかを特定した.
- apoB100とLDLRの病気に関連した変異は,LDL-LDLRインターフェイスに局所されています.
結論:
- アポB100-LDLR複合体の構造的な詳細を 提供しています
- 家族性高コレステロール血症におけるLDL結合と潜在的なLDLR機能障害の構造的根拠を説明する.
- 高コレステロール血症を理解し,潜在的に治療するための重要なサイトとしてLDL-LDLRインターフェースを強調します.
関連する概念動画
01:39Receptor-mediated Endocytosis
104.0K
Overview
104.0K
01:29Drug Distribution: Plasma Protein Binding
4.9K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
4.9K
01:30Drug Binding to Blood Components
110
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
110
01:45Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
00:59COP Coated Vesicles
7.7K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
7.7K
01:12Clathrin Coated Vesicles
6.8K
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
6.8K